• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA 和 microRNA 网络在肝细胞癌及其肿瘤微环境中的作用。

The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.

机构信息

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan.

出版信息

Int J Mol Sci. 2021 Sep 30;22(19):10630. doi: 10.3390/ijms221910630.

DOI:10.3390/ijms221910630
PMID:34638971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8508708/
Abstract

Hepatocellular carcinoma (HCC) is a common liver malignancy with high morbidity and poor prognosis. Long non-coding RNAs (lncRNAs) are involved in crucial biological processes of tumorigenesis and progression, and play four major regulatory roles, namely signal, decoy, guide, and scaffold, to regulate gene expression. Through these processes, lncRNAs can target microRNAs (miRNAs) to form lncRNA and miRNA networks, which regulate cancer cell proliferation, metastasis, drug resistance, and the tumor microenvironment. Here, we summarize the multifaceted functions of lncRNA and miRNA networks in the pathogenesis of HCC, the potential use of diagnostic or prognostic biomarkers, and novel therapeutic targets in HCC. This review also highlights the regulatory effects of lncRNA and miRNA networks in the tumor microenvironment of HCC.

摘要

肝细胞癌(HCC)是一种常见的肝脏恶性肿瘤,发病率高,预后差。长链非编码 RNA(lncRNA)参与肿瘤发生和发展的关键生物学过程,发挥四种主要的调控作用,即信号、诱饵、指导和支架,以调节基因表达。通过这些过程,lncRNA 可以靶向 microRNAs(miRNA)形成 lncRNA 和 miRNA 网络,调节癌细胞的增殖、转移、耐药性和肿瘤微环境。在这里,我们总结了 lncRNA 和 miRNA 网络在 HCC 发病机制中的多方面功能,以及其在 HCC 诊断或预后生物标志物和新治疗靶点中的潜在应用。本综述还强调了 lncRNA 和 miRNA 网络在 HCC 肿瘤微环境中的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/8508708/af8f4aa35e65/ijms-22-10630-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/8508708/1a0b2d8ac4c9/ijms-22-10630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/8508708/af8f4aa35e65/ijms-22-10630-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/8508708/1a0b2d8ac4c9/ijms-22-10630-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0f5/8508708/af8f4aa35e65/ijms-22-10630-g002.jpg

相似文献

1
The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.长链非编码 RNA 和 microRNA 网络在肝细胞癌及其肿瘤微环境中的作用。
Int J Mol Sci. 2021 Sep 30;22(19):10630. doi: 10.3390/ijms221910630.
2
Non-coding RNA in drug resistance of hepatocellular carcinoma.非编码 RNA 在肝癌耐药中的作用。
Biosci Rep. 2018 Oct 9;38(5). doi: 10.1042/BSR20180915. Print 2018 Oct 31.
3
Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.血清外泌体长非编码 RNA lnc-FAM72D-3 和 lnc-EPC1-4 作为肝细胞癌的诊断生物标志物。
Aging (Albany NY). 2020 Jun 18;12(12):11843-11863. doi: 10.18632/aging.103355.
4
lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.lncRNA-D16366 是肝细胞癌诊断和预后的潜在生物标志物。
Med Sci Monit. 2019 Sep 2;25:6581-6586. doi: 10.12659/MSM.915100.
5
Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.构建疾病特异性 lncRNA-miRNA-mRNA 调控网络揭示肝癌潜在的调控轴和预后生物标志物。
Cancer Med. 2020 Dec;9(24):9219-9235. doi: 10.1002/cam4.3526. Epub 2020 Nov 24.
6
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.微小 RNA 和长链非编码 RNA 在肝癌耐药中的新兴作用。
Mol Cancer. 2019 Oct 25;18(1):147. doi: 10.1186/s12943-019-1086-z.
7
Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.长链非编码 RNA 作为肿瘤微环境与肝癌细胞通讯的介体。
Int J Mol Sci. 2018 Nov 24;19(12):3742. doi: 10.3390/ijms19123742.
8
The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus.肝细胞癌中的 mRNA、miRNA 和 lncRNA 网络:来自基因表达综合分析。
Mol Med Rep. 2018 May;17(5):6472-6482. doi: 10.3892/mmr.2018.8694. Epub 2018 Mar 7.
9
Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.与肝细胞癌相关的潜在转录因子、长链非编码RNA和微小RNA的鉴定。
J Cancer Res Ther. 2018 Sep;14(Supplement):S622-S627. doi: 10.4103/0973-1482.204846.
10
Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.全面分析竞争性内源性 circRNA-lncRNA-miRNA-mRNA 网络,并鉴定肝癌的新型潜在生物标志物。
Aging (Albany NY). 2021 May 28;13(12):15990-16008. doi: 10.18632/aging.203056.

引用本文的文献

1
The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma.肝细胞癌中长链非编码RNA的表观遗传调控网络
Genes Dis. 2025 Jan 20;12(5):101534. doi: 10.1016/j.gendis.2025.101534. eCollection 2025 Sep.
2
SNHG19 promotes the proliferation and metastasis of hepatocellular carcinoma through regulating the miR-137/protein tyrosine phosphatase 4A3 axis.SNHG19通过调控miR-137/蛋白酪氨酸磷酸酶4A3轴促进肝细胞癌的增殖和转移。
SAGE Open Med. 2025 Apr 21;13:20503121251334272. doi: 10.1177/20503121251334272. eCollection 2025.
3
Non-coding RNA-mediated granulosa cell dysfunction during ovarian aging: From mechanisms to potential interventions.

本文引用的文献

1
TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells.转化生长因子-β-转移相关蛋白1-小母亲抗五聚体蛋白7-小母亲抗五聚体蛋白3-性别决定区Y框蛋白4-增强子zeste同源物2信号轴促进肝癌细胞的生存能力、迁移、侵袭和上皮-间质转化
Cancer Manag Res. 2021 Sep 10;13:7087-7099. doi: 10.2147/CMAR.S297765. eCollection 2021.
2
Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma.探索端粒酶逆转录酶与β-连环蛋白在肝细胞癌中的相互作用
Cancers (Basel). 2021 Aug 20;13(16):4202. doi: 10.3390/cancers13164202.
3
Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.
非编码RNA介导的卵巢衰老过程中的颗粒细胞功能障碍:从机制到潜在干预措施。
Noncoding RNA Res. 2025 Mar 3;12:102-115. doi: 10.1016/j.ncrna.2025.03.001. eCollection 2025 Jun.
4
Molecular regulators of alcoholic liver disease: a comprehensive analysis of microRNAs and long non-coding RNAs.酒精性肝病的分子调节因子:对微小RNA和长链非编码RNA的综合分析
Front Med (Lausanne). 2025 Mar 10;12:1482089. doi: 10.3389/fmed.2025.1482089. eCollection 2025.
5
MicroRNA MTCO3P38 Inhibits the TMOD1/MMP13 Pathway to Alleviate the Progression of Hepatocellular Carcinoma.微小RNA MTCO3P38通过抑制TMOD1/MMP13通路减轻肝细胞癌进展
J Cancer. 2025 Jan 1;16(2):486-495. doi: 10.7150/jca.100556. eCollection 2025.
6
Analysis of four long non-coding RNAs for hepatocellular carcinoma screening and prognosis by the aid of machine learning techniques.利用机器学习技术分析四种长非编码 RNA 用于肝细胞癌筛查和预后
Sci Rep. 2024 Nov 28;14(1):29582. doi: 10.1038/s41598-024-80926-w.
7
Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma: An In-Depth Review.探讨β-连环蛋白突变在肝细胞癌中的作用:深入综述。
Cancer Control. 2024 Jan-Dec;31:10732748241293680. doi: 10.1177/10732748241293680.
8
Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy.乙型肝炎病毒相关肝脏恶性肿瘤的分子和遗传信号作为诊断和治疗靶点的最新进展。
Heliyon. 2024 Jul 8;10(14):e34288. doi: 10.1016/j.heliyon.2024.e34288. eCollection 2024 Jul 30.
9
miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.微小RNA和长链非编码RNA作为肝细胞癌潜在的组织生物标志物
Noncoding RNA Res. 2023 Oct 24;9(1):24-32. doi: 10.1016/j.ncrna.2023.10.010. eCollection 2024 Mar.
10
Exploring the Regulatory Role of XIST-microRNAs/mRNA Network in Circulating CD4 T Cells of Hepatocellular Carcinoma Patients.探索XIST-微小RNA/信使核糖核酸网络在肝癌患者循环CD4 T细胞中的调控作用。
Biomedicines. 2023 Jun 27;11(7):1848. doi: 10.3390/biomedicines11071848.
免疫细胞的代谢重编程:塑造肝细胞癌的肿瘤微环境。
Cancer Med. 2021 Sep;10(18):6374-6383. doi: 10.1002/cam4.4177. Epub 2021 Aug 13.
4
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer.肝癌中的缺氧、代谢重编程与耐药性
Cells. 2021 Jul 6;10(7):1715. doi: 10.3390/cells10071715.
5
Role of Oncogenic Pathways on the Cancer Immunosuppressive Microenvironment and Its Clinical Implications in Hepatocellular Carcinoma.致癌通路在肝癌免疫抑制微环境中的作用及其临床意义
Cancers (Basel). 2021 Jul 21;13(15):3666. doi: 10.3390/cancers13153666.
6
The Role of microRNAs in Cholangiocarcinoma.微小 RNA 在胆管癌中的作用。
Int J Mol Sci. 2021 Jul 16;22(14):7627. doi: 10.3390/ijms22147627.
7
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.TGF-β 信号通路:从组织纤维化到肿瘤微环境。
Int J Mol Sci. 2021 Jul 15;22(14):7575. doi: 10.3390/ijms22147575.
8
MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular Carcinoma.微小RNA-424作为肝细胞癌患者诊断的新型生物标志物。
Cancer Biother Radiopharm. 2023 Dec;38(10):670-673. doi: 10.1089/cbr.2020.4141. Epub 2021 Jul 20.
9
m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling.m6A诱导的长链非编码RNA MEG3通过miR-544b/BTG2信号通路抑制肝癌细胞的增殖、迁移和侵袭
Onco Targets Ther. 2021 Jun 15;14:3745-3755. doi: 10.2147/OTT.S289198. eCollection 2021.
10
Noncoding RNA therapeutics - challenges and potential solutions.非编码 RNA 治疗学——挑战与潜在解决方案。
Nat Rev Drug Discov. 2021 Aug;20(8):629-651. doi: 10.1038/s41573-021-00219-z. Epub 2021 Jun 18.